Vanderbilt University School of Medicine

Moore, Daniel J , MD, PhD
Assistant Professor of Pediatrics
Assistant Professor of Pathology, Microbiology and Immunology

Lab Url:

Phone Number: 322-7427


Moore, Daniel's picture

Office Address   Mailing Address

11136 Doctors Office Tower

11136 DOT 37232

Research Keywords
Autoimmunity Immune Tolerance transplantation biology Type 1 diabetes Allotransplantation Regulatory T cells Regulatory B cells Innate Immunity Inflammation,Diabetes,Endocrinology,Immunology,Mouse,Translation,Transplantation

Research Specialty
The overall goal of my research program is to induce life-long immune tolerance to specific self and foreign (transplantation) antigens in individuals with pre-existing autoimmune disease.

Research Description
Our research seeks to understand the cellular and molecular mechanisms that govern immune tolerance in order to prevent and reverse Type 1 Diabetes and enhance the success of organ transplantation. My graduate research as an MSTP student at Penn contributed to the understanding of the role played by B lymphocytes in the development of autoimmune disease. This research formed part of the foundation for current efforts to use B cell directed therapies to prevent diabetes, studies in which Vanderbilt is participating through the Type 1 Diabetes TrialNet and for which I participate as a co-investigator. We also previously extended these studies to demonstrate that B lymphocytes are absolutely required for some forms of transplantation tolerance induction in murine models. These studies suggest the presence of regulatory B cells which have yet to be defined. A main present focus of the lab, supported by an NIH K08 and other sources, is to understand how B lymphocytes regulate immune tolerance to transplants and how this cell type participates in broken tolerance in autoimmune disease such as Type 1 diabetes.

As part of a comprehensive program to understand immune regulation, we also actively investigate the mechanism of action of regulatory T lymphocytes which are critical for the prevention of autoimmune disease and for the establishment of transplantation tolerance. This research has revealed several new interactions required for the development and function of these cells and has identified inflammation as a factor that counter-regulates these regulatory cells. To overcome this newly identified obstacle to immune tolerance, I collaborate with Jacek Hawiger, M.D., Ph.D. and we have successfully applied a new kind of anti-inflammatory therapy to the prevention of diabetes in a pre-clinical model of disease (PLOS One, 2010).

My research has been funded by the National Institutes of Health, the American Diabetes Association, and the Juvenile Diabetes Research Foundation. I serve as a reviewer for the Journal of Immunology, Diabetes, the American Journal of Transplantation, and the Annals of the New York Academy of Science. Our research has been presented at the Scientific Sessions of the American Diabetes Association, the annual meeting of the Pediatric Academic Societies, and the American Transplant Congress. We have published in the Journal of Immunology, Diabetes, Transplantation International, the Journal of Autoimmunity, and Nature Medicine. Our research program has also been recognized by the Society for Pediatric Research with the 2007 House Officer Research Award and by Vanderbilt University with the David Karzon, Joe M. Strayhorn, Elliot V. Newman, and Vanderbilt Scholar in Diabetes Awards.

Clinical Research Description
Our laboratory, while focused on the basic science of autoimmunity and immune tolerance, constantly evaluates opportunities to translate our research into clinical application. These efforts include an interest in specifying the immunophenotype of individuals with autoimmunity and in identifying unique risk factors that predict autoimmune disease.

Clinical Interests
My primary interest is the optimal management of Type 1 diabetes. This focus complements my fundamental research interest in developing a cure for Type 1 diabetes by providing outstanding care while our patients wait on the development of a cure.

Datye, KA, Moore, DJ, Russell, WE, Jaser, SS. A Review of Adolescent Adherence in Type 1 Diabetes and the Untapped Potential of Diabetes Providers to Improve Outcomes. Curr Diab Rep, 15(8), 621, 2015.

Sosenko, JM, Skyler, JS, DiMeglio, LA, Beam, CA, Krischer, JP, Greenbaum, CJ, Boulware, D, Rafkin, LE, Matheson, D, Herold, KC, Mahon, J, Palmer, JP, , , , . A new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history. Diabetes Care, 38(2), 271-6, 2015.

Stocks, BT, Wilhelm, AJ, Wilson, CS, Marshall, AF, Putnam, NE, Major, AS, Moore, DJ. Lupus-Prone Mice Resist Immune Regulation and Transplant Tolerance Induction. Am J Transplant, , , 2015.

Wilson, CS, Elizer, SK, Marshall, AF, Stocks, BT, Moore, DJ. The Regulation of B Lymphocyte Responses to TLR Ligation During Diabetes Prevention in NOD Mice. J Diabetes, , , 2015.

Wynn, JL, Scumpia, PO, Stocks, BT, Romano-Keeler, J, Alrifai, MW, Liu, JH, Kim, AS, Alford, CE, Matta, P, Weitkamp, JH, Moore, DJ. Neonatal CD71+ Erythroid Cells Do Not Modify Murine Sepsis Mortality. J Immunol, , , 2015.

DiGiandomenico, A, Veach, RA, Zienkiewicz, J, Moore, DJ, Wylezinski, LS, Hutchens, MA, Hawiger, J. The "Genomic Storm" Induced by Bacterial Endotoxin Is Calmed by a Nuclear Transport Modifier That Attenuates Localized and Systemic Inflammation. PLoS One, 9(10), e110183, 2014.

Elizer, SK, Marshall, AF, Moore, DJ. Dysregulation of T Lymphocyte Proliferative Responses in Autoimmunity. PLoS One, 9(8), e106347, 2014.

Romano-Keeler, J, Moore, DJ, Wang, C, Brucker, RM, Fonnesbeck, C, Slaughter, JC, Li, H, Curran, DP, Meng, S, Correa, H, Lovvorn, HN, Tang, YW, Bordenstein, S, George, AL, Weitkamp, JH. Early life establishment of site-specific microbial communities in the gut. Gut Microbes, 5(2), , 2014.

Weitkamp, JH, Rosen, MJ, Zhao, Z, Koyama, T, Geem, D, Denning, TL, Rock, MT, Moore, DJ, Halpern, MD, Matta, P, Denning, PW. Small Intestinal Intraepithelial TCR????+ T Lymphocytes Are Present in the Premature Intestine but Selectively Reduced in Surgical Necrotizing Enterocolitis. PLoS One, 9(6), e99042, 2014.

Zhao, G, Moore, DJ, Kim, JI, Lee, KM, O''Connor, M, Yang, M, Marshall, AF, Lei, J, Schuetz, C, Markmann, JF, Deng, S. An immunosufficient murine model for the study of human islets. Xenotransplantation, , , 2014.

Gregory, JM, Moore, DJ, Simmons, JH. Type 1 diabetes mellitus. Pediatr Rev, 34(5), 203-15, 2013.

Liu, Y, Major, AS, Zienkiewicz, J, Gabriel, CL, Veach, RA, Moore, DJ, Collins, RD, Hawiger, J. Nuclear transport modulation reduces hypercholesterolemia, atherosclerosis, and Fatty liver. J Am Heart Assoc, 2(2), e000093, 2013.

Mouledoux, JH, Albers, EL, Lu, Z, Saville, BR, Moore, DJ, Dodd, DA. Clinical predictors of autoimmune and severe atopic disease in pediatric heart transplant recipients. Pediatr Transplant, , , 2013.

Sosenko, JM, Skyler, JS, Beam, CA, Krischer, JP, Greenbaum, CJ, Mahon, J, Rafkin, LE, Matheson, D, Herold, KC, Palmer, JP, , . Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participants. Diabetes, 62(12), 4179-83, 2013.

Sosenko, JM, Skyler, JS, Palmer, JP, Krischer, JP, Yu, L, Mahon, J, Beam, CA, Boulware, DC, Rafkin, L, Schatz, D, Eisenbarth, G, , , , . The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients. Diabetes Care, 36(9), 2615-20, 2013.

Virostko, J, Radhika, A, Poffenberger, G, Dula, AN, Moore, DJ, Powers, AC. Bioluminescence Imaging Reveals Dynamics of Beta Cell Loss in the Non-Obese Diabetic (NOD) Mouse Model. PLoS One, 8(3), e57784, 2013.

Yeh, H, Moore, DJ, Markmann, JF, Kim, JI. Mechanisms of regulatory T cell counter-regulation by innate immunity. Transplant Rev (Orlando), , , 2013.

. The Effects of Inpatient Hybrid Closed-Loop Therapy Initiated Within 1 Week of Type 1 Diabetes Diagnosis Diabetes Research in Children Network (DirecNet) and Type 1 Diabetes TrialNet Study Groups (*). Diabetes Technol Ther, 15(5), 401-8, 2013.

Buscariollo, DL, Davidson, MA, Black, M, Russell, WE, Rothman, RL, Moore, DJ. Factors That Influence Parental Attitudes toward Enrollment in Type 1 Diabetes Trials. PLoS One, 7(8), e44341, 2012.

Engelhardt, BG, Jagasia, SM, Crowe, JE, Griffith, ML, Savani, BN, Kassim, AA, Lu, P, Weitkamp, JH, Moore, DJ, Yoder, SM, Rock, MT, Jagasia, M. Predicting post-transplant diabetes mellitus by regulatory T cell phenotype: implications for metabolic intervention to modulate alloreactivity. Blood, , , 2012.

Lin, Q, Liu, Y, Moore, DJ, Elizer, SK, Veach, RA, Hawiger, J, Ruley, HE. Cutting Edge: The "Death" Adaptor CRADD/RAIDD Targets BCL10 and Suppresses Agonist-Induced Cytokine Expression in T Lymphocytes. J Immunol, , , 2012.

Romano-Keeler, J, Weitkamp, JH, Moore, DJ. Regulatory properties of the intestinal microbiome effecting the development and treatment of diabetes. Curr Opin Endocrinol Diabetes Obes, , , 2012.

Shoemaker, AH, Zienkiewicz, J, Moore, DJ. Clinical assessment of HNF1A and GCK variants and identification of a novel mutation causing MODY2. Diabetes Res Clin Pract, , , 2012.

Weitkamp, JH, Koyama, T, Rock, MT, Correa, H, Goettel, JA, Matta, P, Oswald-Richter, K, Rosen, MJ, Engelhardt, BG, Moore, DJ, Polk, DB. Necrotising enterocolitis is characterised by disrupted immune regulation and diminished mucosal regulatory (FOXP3)/effector (CD4, CD8) T cell ratios. Gut, , , 2012.

Yu, L, Boulware, DC, Beam, CA, Hutton, JC, Wenzlau, JM, Greenbaum, CJ, Bingley, PJ, Krischer, JP, Sosenko, JM, Skyler, JS, Eisenbarth, GS, Mahon, JL, , . Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies. Diabetes Care, 35(6), 1213-8, 2012.

Gregory, JM, Moore, DJ. Can technological solutions for diabetes replace islet cell function. Organogenesis, 7(1), 32-41, 2011.

Mathew, RP, Moore, DJ. Autoimmune Alternating Hypo- and Hyperthyroidism in Children. Clin Pediatr (Phila), 50(11), 1040-4, 2011.

Orban, T, Bundy, B, Becker, DJ, DiMeglio, LA, Gitelman, SE, Goland, R, Gottlieb, PA, Greenbaum, CJ, Marks, JB, Monzavi, R, Moran, A, Raskin, P, Rodriguez, H, Russell, WE, Schatz, D, Wherrett, D, Wilson, DM, Krischer, JP, Skyler, JS, , . Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial. Lancet, 378(9789), 412-9, 2011.

Zhao, G, Moore, DJ, Kim, JI, Lee, KM, O''Connor, MR, Duff, PE, Yang, M, Lei, J, Markmann, JF, Deng, S. Inhibition of transplantation tolerance by immune senescence is reversed by endocrine modulation. Sci Transl Med, 3(87), 87ra52, 2011.

Kim, JI, Sonawane, SB, Lee, MK, Lee, SH, Duff, PE, Moore, DJ, O''Connor, MR, Lian, MM, Deng, S, Choi, Y, Yeh, H, Caton, AJ, Markmann, JF. Blockade of GITR-GITRL interaction maintains Treg function to prolong allograft survival. Eur J Immunol, 40(5), 1369-74, 2010. PMCID:2935584

Moore, DJ. Accounting for chance in the calculus of autoimmune disease. Med Hypotheses, 74(2), 289-93, 2010. PMCID:2970569

Moore, DJ, Zienkiewicz, J, Kendall, PL, Liu, D, Liu, X, Veach, RA, Collins, RD, Hawiger, J. In vivo islet protection by a nuclear import inhibitor in a mouse model of type 1 diabetes. PLoS One, 5(10), e13235, 2010. PMCID:2950856

Zhao, G, Moore, DJ, Lee, KM, Kim, JI, Duff, PE, O''Connor, MR, Hirohashi, T, Lei, J, Yang, M, Markmann, JF, Deng, S. An unexpected counter-regulatory role of IL-10 in B-lymphocyte-mediated transplantation tolerance. Am J Transplant, 10(4), 796-801, 2010. PMCID:2934759

Kendall, PL, Moore, DJ, Hulbert, C, Hoek, KL, Khan, WN, Thomas, JW. Reduced diabetes in btk-deficient nonobese diabetic mice and restoration of diabetes with provision of an anti-insulin IgH chain transgene. J Immunol, 183(10), 6403-12, 2009. PMCID:2970569

Kim, JI, Lee, MK, Moore, DJ, Sonawane, SB, Duff, PE, O''Connor, MR, Yeh, H, Lian, MM, Deng, S, Caton, AJ, Markmann, JF. Regulatory T-cell counter-regulation by innate immunity is a barrier to transplantation tolerance. Am J Transplant, 9(12), 2736-44, 2009. PMCID:2796697

Moore, DJ, Gregory, JM, Kumah-Crystal, YA, Simmons, JH. Mitigating micro-and macro-vascular complications of diabetes beginning in adolescence. Vasc Health Risk Manag, 5, 1015-31, 2009. PMCID:2788594

Sonawane, SB, Kim, JI, Lee, MK, Lee, SH, Duff, PE, Moore, DJ, Lian, MM, Deng, S, Choi, Y, Yeh, H, Caton, AJ, Markmann, JF. GITR Blockade Facilitates Treg Mediated Allograft Survival. Transplantation, 88(10), 1169-77, 2009. PMCID:2803064

Huang, X, Moore, DJ, Ketchum, RJ, Nunemaker, CS, Kovatchev, B, McCall, AL, Brayman, KL. Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation. Endocr Rev, 29(5), 603-30, 2008. PMCID:2819735

Huang, X, Moore, DJ, Mohiuddin, M, Lian, MM, Kim, JI, Sonawane, S, Wang, J, Gu, Y, Yeh, H, Markmann, JF, Deng, S. Inhibition of ICAM-1/LFA-1 interactions prevents B-cell-dependent anti-CD45RB-induced transplantation tolerance. Transplantation, 85(5), 675-80, 2008. PMCID:2934773

Deng, S, Moore, DJ, Huang, X, Lian, MM, Mohiuddin, M, Velededeoglu, E, Lee, MK, Sonawane, S, Kim, J, Wang, J, Chen, H, Corfe, SA, Paige, C, Shlomchik, M, Caton, A, Markmann, JF. Cutting edge: transplant tolerance induced by anti-CD45RB requires B lymphocytes. J Immunol, 178(10), 6028-32, 2007. PMCID:2934773

Moore, DJ, Kim, JI, Sonawane, S, Yeh, H, Deng, S, Lee, K, Markmann, JF. Progress toward antibody-induced transplantation tolerance. Crit Rev Immunol, 27(2), 167-218, 2007. PMCID:2934773

Porrett, PM, Lee, MK, Lian, MM, Wang, J, Caton, AJ, Deng, S, Markmann, JF, Moore, DJ. A direct comparison of rejection by CD8 and CD4 T cells in a transgenic model of allotransplantation. Arch Immunol Ther Exp (Warsz), 56(3), 193-200, 2007. PMCID:2766493

Deng, S, Moore, DJ, Huang, X, Mohiuddin, M, Lee, MK, Velidedeoglu, E, Lian, MM, Chiaccio, M, Sonawane, S, Orlin, A, Wang, J, Chen, H, Caton, A, Zhong, R, Markmann, JF. Antibody-induced transplantation tolerance that is dependent on thymus-derived regulatory T cells. J Immunol, 176(5), 2799-807, 2006. PMCID:2934773

Lee, MK, Moore, DJ, Chiaccio, M, Lian, MM, Deng, S, Mohiuddin, M, Huang, X, Koeberlein, B, Zakheim, A, Porrett, PM, Barker, CF, Caton, AJ, Markmann, JF. T-reg mediated suppression of the allograft response in the draining lymph node. Transplantation, 81(7), 1063-6, 2006. PMCID:2934773

Moore, DJ, Markmann, JF, Deng, S. Avenues for immunomodulation and graft protection by gene therapy in transplantation. Transpl Int, 19(6), 435-45, 2006. PMCID:2934773

Moore, DJ, Noorchashm, H, Lin, TH, Greeley, SA, Naji, A. NOD B-cells are insufficient to incite T-cell-mediated anti-islet autoimmunity. Diabetes, 54(7), 2019-25, 2005. PMCID:2934773

Wilde, GE, Moore, DJ, Bellah, RD. Posttransplantation lymphoproliferative disorder in pediatric recipients of solid organ transplants: timing and location of disease. AJR Am J Roentgenol, 185(5), 1335-41, 2005. PMCID:2934773

Lee, MK, Moore, DJ, Jarrett, BP, Lian, MM, Deng, S, Huang, X, Markmann, JW, Chiaccio, M, Barker, CF, Caton, AJ, Markmann, JF. Promotion of allograft survival by CD4+CD25+ regulatory T cells: evidence for in vivo inhibition of effector cell proliferation. J Immunol, 172(11), 6539-44, 2004. PMCID:2934773

Moore, DJ, Huang, X, Lee, MK, Lian, MM, Chiaccio, M, Chen, H, Koeberlein, B, Zhong, R, Markmann, JF, Deng, S. Resistance to anti-CD45RB-induced tolerance in NOD mice: mechanisms involved. Transpl Int, 17(5), 261-9, 2004. PMCID:2934773

Lee, MK, Huang, X, Jarrett, BP, Moore, DJ, Desai, NM, Moh Lian, M, Markmann, JW, Deng, S, Frank, A, Singer, A, Velidedeoglu, E, Caton, AJ, Markmann, AJ. Vulnerability of allografts to rejection by MHC class II-restricted T-cell receptor transgenic mice. Transplantation, 75(8), 1415-22, 2003. PMCID:2934773

Lee, MK, Moore, DJ, Markmann, JF. Regulatory CD4+CD25+T cells in prevention of allograft rejection. Front Biosci, 8, s968-81, 2003. PMCID:2934773

Song, HK, Noorchashm, H, Lin, TH, Moore, DJ, Greeley, SA, Caton, AJ, Naji, A. Specialized CC-chemokine secretion by Th1 cells in destructive autoimmune myocarditis. J Autoimmun, 21(4), 295-303, 2003. PMCID:2934773

Trani, J, Moore, DJ, Jarrett, BP, Markmann, JW, Lee, MK, Singer, A, Lian, MM, Tran, B, Caton, AJ, Markmann, JF. CD25+ immunoregulatory CD4 T cells mediate acquired central transplantation tolerance. J Immunol, 170(1), 279-86, 2003. PMCID:2934773

Greeley, SA, Katsumata, M, Yu, L, Eisenbarth, GS, Moore, DJ, Goodarzi, H, Barker, CF, Naji, A, Noorchashm, H. Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat Med, 8(4), 399-402, 2002.

Velidedeoglu, E, Jarret, B, Lee, K, Moore, D, Huang, X, Deng, S, Lian, MM, Caton, A, Markmann, JF. Transgenic T cells persist in an adoptive transfer model of mouse liver transplantation tolerance. Transplant Proc, 34(8), 3342-4, 2002. PMCID:2934773

Greeley, SA, Moore, DJ, Noorchashm, H, Noto, LE, Rostami, SY, Schlachterman, A, Song, HK, Koeberlein, B, Barker, CF, Naji, A. Impaired activation of islet-reactive CD4 T cells in pancreatic lymph nodes of B cell-deficient nonobese diabetic mice. J Immunol, 167(8), 4351-7, 2001.

Kline, JB, Moore, DJ, Clevenger, CV. Activation and association of the Tec tyrosine kinase with the human prolactin receptor: mapping of a Tec/Vav1-receptor binding site. Mol Endocrinol, 15(5), 832-41, 2001.

Noorchashm, H, Moore, DJ, Noto, LE, Noorchashm, N, Reed, AJ, Reed, AL, Song, HK, Mozaffari, R, Jevnikar, AM, Barker, CF, Naji, A. Impaired CD4 T cell activation due to reliance upon B cell-mediated costimulation in nonobese diabetic (NOD) mice. J Immunol, 165(8), 4685-96, 2000.

Noorchashm, H, Moore, DJ, Lieu, YK, Noorchashm, N, Schlachterman, A, Song, HK, Barker, CF, Naji, A. Contribution of the innate immune system to autoimmune diabetes: a role for the CR1/CR2 complement receptors. Cell Immunol, 195(1), 75-9, 1999.

Shimada, H, Germana, S, Sonntag, KC, Banerjee, P, Moore, D, Sachs, DH, LeGuern, C. MHC class II alpha/beta heterodimeric cell surface molecules expressed from a single proviral genome. Hum Gene Ther, 10(14), 2397-405, 1999.

Postdoctoral Position Available

Postdoctoral Position Details
We would welcome a highly motivated, energetic investigator to join our team and lead a translational project defining new models of human autoimmune disease. Experience in human immunology, mouse models of autoimmunity and diabetes, and methods in cellular and molecular immunology is highly desirable.

Updated Date

Vanderbilt University is committed to principles of equal opportunity and affirmative action.
Copyright 2008 Vanderbilt University School of Medicine
The office of Biomedical Research Education & Training All rights reserved.
For questions or problems concerning this page, please submit a help ticket.